Research and Markets: BioSante Pharmaceuticals, Inc. - Product Pipeline Review - 2012

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/lthg5g/biosante) has announced the addition of Global Markets Direct's new company profile "BioSante Pharmaceuticals, Inc. - Product Pipeline Review - 2012" to their offering.

This report provides data on the BioSante Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.


- Brief BioSante Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.

- Review of current pipeline of BioSante Pharmaceuticals, Inc. human therapeutic division.

- Overview of pipeline therapeutics across various therapy areas.

- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.

- Product profiles for late stage and clinical stage products of BioSante Pharmaceuticals, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.

- Recent updates of the BioSante Pharmaceuticals, Inc.'s pipeline in the last quarter.

- Key discontinued and dormant projects.

- Latest news and deals relating to the products.

Reasons to Buy:

- Evaluate BioSante Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline.

- Assess the growth potential of BioSante Pharmaceuticals, Inc. in its therapy areas of focus.

- Identify new drug targets and therapeutic classes in the BioSante Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.

- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.

- Exploit collaboration and partnership opportunities with BioSante Pharmaceuticals, Inc..

- Avoid Intellectual Property Rights related issues.

- Explore the dormant and discontinued projects of BioSante Pharmaceuticals, Inc. and identify potential opportunities in those areas.

For more information visit http://www.researchandmarkets.com/research/lthg5g/biosante

Source: Global Markets Direct

Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Source: Research and Markets